Global Cytotoxicity Testing Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI04252477

Publication Date:

April 25, 2025

Pages:

131

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Cytotoxicity Testing market size is predicted to grow from US$ 15620 million in 2025 to US$ 25790 million in 2031; it is expected to grow at a CAGR of 8.7% from 2025 to 2031.
The Cytotoxicity Test is designed to evaluate the general toxicity of medical devices and materials. Testing involves extracting devices in a cell culture media and then exposing the extract fluid to mouse fibroblast cells.
Cytotoxicity Testing Market: Growing Demand Driven by Rising Pharmaceutical R&D and Regulatory Stringency
The global cytotoxicity testing market is expected to witness significant growth in the coming years, fueled by several key factors:
Rising pharmaceutical research and development: Increased investments in drug discovery and development are leading to a higher demand for cytotoxicity testing services to assess the safety and efficacy of new drugs.
Stringent regulatory requirements: Regulatory agencies like the FDA and EMA are imposing stricter regulations on the safety of drugs and medical devices, mandating comprehensive cytotoxicity testing.
Growing awareness of safety concerns: Increasing awareness about the potential toxicity of drugs, medical devices, and consumer products is driving the demand for cytotoxicity testing to ensure the safety of these products.
Advances in technology: Technological advancements are leading to the development of more sensitive, specific, and high-throughput cytotoxicity testing methods, making them more efficient and cost-effective.
Outsourcing trend: Pharmaceutical and biotechnology companies are increasingly outsourcing their cytotoxicity testing needs to specialized contract research organizations (CROs) due to expertise and cost considerations.
Market Trends:
Integration of automation and data analytics: Integrating cytotoxicity testing with automation and data analytics systems is enhancing efficiency, data traceability, and decision-making capabilities.
Focus on high-throughput screening (HTS): HTS methods are increasingly being used to screen large libraries of compounds for potential cytotoxicity, leading to faster drug discovery and development.
Development of 3D cell culture models: 3D cell culture models are becoming increasingly popular for cytotoxicity testing as they provide a more realistic environment for assessing the effects of substances on living cells.
Focus on personalized medicine: Personalized cytotoxicity testing approaches are being developed to tailor testing protocols to individual patients based on their genetic makeup and other factors.
Technological advancements: Advancements in areas like microfluidics and nanotechnology are leading to the development of new and improved cytotoxicity testing methods.
Challenges and Opportunities:
Stringent regulatory compliance requirements: Maintaining compliance with evolving regulatory requirements can be challenging for testing laboratories, requiring continuous investments in technology and expertise.
Competition from new entrants: The market is becoming increasingly competitive with the entry of new players, putting pressure on established companies to innovate and offer cost-effective solutions.
Rapid technological advancements: Keeping pace with rapid technological advancements and the constant evolution of testing methods requires significant investments in research and development.
The future of the cytotoxicity testing market is optimistic, driven by the increasing demand for safe and effective drugs, medical devices, and consumer products, stringent regulatory requirements, and ongoing technological advancements. By focusing on innovation, automation, cost-effectiveness, and expansion into emerging markets, testing service providers can ensure their competitiveness and contribute to enhancing patient safety and product quality.
The 鈥淐ytotoxicity Testing Industry Forecast鈥� looks at past sales and reviews total world Cytotoxicity Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Cytotoxicity Testing sales for 2025 through 2031. With Cytotoxicity Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cytotoxicity Testing industry.
This Insight Report provides a comprehensive analysis of the global Cytotoxicity Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cytotoxicity Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Cytotoxicity Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cytotoxicity Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cytotoxicity Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Cytotoxicity Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Elution Testing Method
Agar Overlay Method
Direct Contact Method
MTT Assay Method
Others
Segmentation by Application:
Medical Device
Medical Accessories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sartorius
UL
Eurofins
SGS
Emery Pharma
Nelson Labs
UFAG Laboratorien AG
Pacific BioLabs
NorthEast BioLab
Biosafe Ltd
Creative Bioarray
Evercyte
IONTOX
Applied StemCell
Xenometrix AG
T脺V S脺D
Medicilon
Huatongwei

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cytotoxicity Testing Market Size (2020-2031)
2.1.2 Cytotoxicity Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Cytotoxicity Testing by Country/Region (2020, 2024 & 2031)
2.2 Cytotoxicity Testing Segment by Type
2.2.1 Elution Testing Method
2.2.2 Agar Overlay Method
2.2.3 Direct Contact Method
2.2.4 MTT Assay Method
2.2.5 Others
2.3 Cytotoxicity Testing Market Size by Type
2.3.1 Cytotoxicity Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Cytotoxicity Testing Market Size Market Share by Type (2020-2025)
2.4 Cytotoxicity Testing Segment by Application
2.4.1 Medical Device
2.4.2 Medical Accessories
2.4.3 Others
2.5 Cytotoxicity Testing Market Size by Application
2.5.1 Cytotoxicity Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Cytotoxicity Testing Market Size Market Share by Application (2020-2025)
3 Cytotoxicity Testing Market Size by Player
3.1 Cytotoxicity Testing Market Size Market Share by Player
3.1.1 Global Cytotoxicity Testing Revenue by Player (2020-2025)
3.1.2 Global Cytotoxicity Testing Revenue Market Share by Player (2020-2025)
3.2 Global Cytotoxicity Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cytotoxicity Testing by Region
4.1 Cytotoxicity Testing Market Size by Region (2020-2025)
4.2 Global Cytotoxicity Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cytotoxicity Testing Market Size Growth (2020-2025)
4.4 APAC Cytotoxicity Testing Market Size Growth (2020-2025)
4.5 Europe Cytotoxicity Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa Cytotoxicity Testing Market Size Growth (2020-2025)
5 Americas
5.1 Americas Cytotoxicity Testing Market Size by Country (2020-2025)
5.2 Americas Cytotoxicity Testing Market Size by Type (2020-2025)
5.3 Americas Cytotoxicity Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cytotoxicity Testing Market Size by Region (2020-2025)
6.2 APAC Cytotoxicity Testing Market Size by Type (2020-2025)
6.3 APAC Cytotoxicity Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cytotoxicity Testing Market Size by Country (2020-2025)
7.2 Europe Cytotoxicity Testing Market Size by Type (2020-2025)
7.3 Europe Cytotoxicity Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cytotoxicity Testing by Region (2020-2025)
8.2 Middle East & Africa Cytotoxicity Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa Cytotoxicity Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cytotoxicity Testing Market Forecast
10.1 Global Cytotoxicity Testing Forecast by Region (2026-2031)
10.1.1 Global Cytotoxicity Testing Forecast by Region (2026-2031)
10.1.2 Americas Cytotoxicity Testing Forecast
10.1.3 APAC Cytotoxicity Testing Forecast
10.1.4 Europe Cytotoxicity Testing Forecast
10.1.5 Middle East & Africa Cytotoxicity Testing Forecast
10.2 Americas Cytotoxicity Testing Forecast by Country (2026-2031)
10.2.1 United States Market Cytotoxicity Testing Forecast
10.2.2 Canada Market Cytotoxicity Testing Forecast
10.2.3 Mexico Market Cytotoxicity Testing Forecast
10.2.4 Brazil Market Cytotoxicity Testing Forecast
10.3 APAC Cytotoxicity Testing Forecast by Region (2026-2031)
10.3.1 China Cytotoxicity Testing Market Forecast
10.3.2 Japan Market Cytotoxicity Testing Forecast
10.3.3 Korea Market Cytotoxicity Testing Forecast
10.3.4 Southeast Asia Market Cytotoxicity Testing Forecast
10.3.5 India Market Cytotoxicity Testing Forecast
10.3.6 Australia Market Cytotoxicity Testing Forecast
10.4 Europe Cytotoxicity Testing Forecast by Country (2026-2031)
10.4.1 Germany Market Cytotoxicity Testing Forecast
10.4.2 France Market Cytotoxicity Testing Forecast
10.4.3 UK Market Cytotoxicity Testing Forecast
10.4.4 Italy Market Cytotoxicity Testing Forecast
10.4.5 Russia Market Cytotoxicity Testing Forecast
10.5 Middle East & Africa Cytotoxicity Testing Forecast by Region (2026-2031)
10.5.1 Egypt Market Cytotoxicity Testing Forecast
10.5.2 South Africa Market Cytotoxicity Testing Forecast
10.5.3 Israel Market Cytotoxicity Testing Forecast
10.5.4 Turkey Market Cytotoxicity Testing Forecast
10.6 Global Cytotoxicity Testing Forecast by Type (2026-2031)
10.7 Global Cytotoxicity Testing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Cytotoxicity Testing Forecast
11 Key Players Analysis
11.1 Sartorius
11.1.1 Sartorius Company Information
11.1.2 Sartorius Cytotoxicity Testing Product Offered
11.1.3 Sartorius Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Sartorius Main Business Overview
11.1.5 Sartorius Latest Developments
11.2 UL
11.2.1 UL Company Information
11.2.2 UL Cytotoxicity Testing Product Offered
11.2.3 UL Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 UL Main Business Overview
11.2.5 UL Latest Developments
11.3 Eurofins
11.3.1 Eurofins Company Information
11.3.2 Eurofins Cytotoxicity Testing Product Offered
11.3.3 Eurofins Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Eurofins Main Business Overview
11.3.5 Eurofins Latest Developments
11.4 SGS
11.4.1 SGS Company Information
11.4.2 SGS Cytotoxicity Testing Product Offered
11.4.3 SGS Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 SGS Main Business Overview
11.4.5 SGS Latest Developments
11.5 Emery Pharma
11.5.1 Emery Pharma Company Information
11.5.2 Emery Pharma Cytotoxicity Testing Product Offered
11.5.3 Emery Pharma Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Emery Pharma Main Business Overview
11.5.5 Emery Pharma Latest Developments
11.6 Nelson Labs
11.6.1 Nelson Labs Company Information
11.6.2 Nelson Labs Cytotoxicity Testing Product Offered
11.6.3 Nelson Labs Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Nelson Labs Main Business Overview
11.6.5 Nelson Labs Latest Developments
11.7 UFAG Laboratorien AG
11.7.1 UFAG Laboratorien AG Company Information
11.7.2 UFAG Laboratorien AG Cytotoxicity Testing Product Offered
11.7.3 UFAG Laboratorien AG Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 UFAG Laboratorien AG Main Business Overview
11.7.5 UFAG Laboratorien AG Latest Developments
11.8 Pacific BioLabs
11.8.1 Pacific BioLabs Company Information
11.8.2 Pacific BioLabs Cytotoxicity Testing Product Offered
11.8.3 Pacific BioLabs Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Pacific BioLabs Main Business Overview
11.8.5 Pacific BioLabs Latest Developments
11.9 NorthEast BioLab
11.9.1 NorthEast BioLab Company Information
11.9.2 NorthEast BioLab Cytotoxicity Testing Product Offered
11.9.3 NorthEast BioLab Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 NorthEast BioLab Main Business Overview
11.9.5 NorthEast BioLab Latest Developments
11.10 Biosafe Ltd
11.10.1 Biosafe Ltd Company Information
11.10.2 Biosafe Ltd Cytotoxicity Testing Product Offered
11.10.3 Biosafe Ltd Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Biosafe Ltd Main Business Overview
11.10.5 Biosafe Ltd Latest Developments
11.11 Creative Bioarray
11.11.1 Creative Bioarray Company Information
11.11.2 Creative Bioarray Cytotoxicity Testing Product Offered
11.11.3 Creative Bioarray Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Creative Bioarray Main Business Overview
11.11.5 Creative Bioarray Latest Developments
11.12 Evercyte
11.12.1 Evercyte Company Information
11.12.2 Evercyte Cytotoxicity Testing Product Offered
11.12.3 Evercyte Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Evercyte Main Business Overview
11.12.5 Evercyte Latest Developments
11.13 IONTOX
11.13.1 IONTOX Company Information
11.13.2 IONTOX Cytotoxicity Testing Product Offered
11.13.3 IONTOX Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 IONTOX Main Business Overview
11.13.5 IONTOX Latest Developments
11.14 Applied StemCell
11.14.1 Applied StemCell Company Information
11.14.2 Applied StemCell Cytotoxicity Testing Product Offered
11.14.3 Applied StemCell Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Applied StemCell Main Business Overview
11.14.5 Applied StemCell Latest Developments
11.15 Xenometrix AG
11.15.1 Xenometrix AG Company Information
11.15.2 Xenometrix AG Cytotoxicity Testing Product Offered
11.15.3 Xenometrix AG Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Xenometrix AG Main Business Overview
11.15.5 Xenometrix AG Latest Developments
11.16 T脺V S脺D
11.16.1 T脺V S脺D Company Information
11.16.2 T脺V S脺D Cytotoxicity Testing Product Offered
11.16.3 T脺V S脺D Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 T脺V S脺D Main Business Overview
11.16.5 T脺V S脺D Latest Developments
11.17 Medicilon
11.17.1 Medicilon Company Information
11.17.2 Medicilon Cytotoxicity Testing Product Offered
11.17.3 Medicilon Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Medicilon Main Business Overview
11.17.5 Medicilon Latest Developments
11.18 Huatongwei
11.18.1 Huatongwei Company Information
11.18.2 Huatongwei Cytotoxicity Testing Product Offered
11.18.3 Huatongwei Cytotoxicity Testing Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Huatongwei Main Business Overview
11.18.5 Huatongwei Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂